Research we are currently funding:
Using models of a bone cancer developed in the lab, Dr Kansara will investigate the effectiveness of targeting a specific immune protein, both alone and in combination with chemotherapy.
Dr Micklethwaite’s team is focusing on new approaches that could boost the body’s own defence mechanisms to kill myeloma cells.
Professor Watkins and his team have shown that osteosarcomas rely on a specific molecular pathway to grow. The team is now researching ways to block this pathway to stop tumour growth.